Quantum Blue® Infliximab - BUHLMANN - Rapid Test

Quantum Blue® IFX

Image

Quantum Blue® IFX
BÜHLMANN Quantum Blue® IFX is the ONLY rapid test to measure IFX in serum samples. Results in just 15 minutes!

Shadow

Quantum Blue® IFX:

BÜHLMANN Quantum Blue® IFX is for Research Use Only in the US.

IFX Trough Level
Over the past two decades great improvements in therapy of chronic inflammatory diseases have been made. The rise of TNFα biologics like infliximab has been a great step forward to ameliorating disease course and keep inflammations at remission levels for prolonged periods of time. Subjects with suboptimal drug concentrations have worse outcomes than those with adequate drug levels. Therapeutic drug monitoring (TDM) for IFX has great potential for the management of anti-TNF therapy.

Studies have shown that targeting an adequate IFX trough level can support guidance of treatment in IBD. An optimal therapeutic window for trough levels seem to be the range from 3 to 7 µg/mL of IFX in serum (Casteele et al., Gastroenterology, 2015).

Quantum Blue® IFX:

  • First rapid test to measure IFX in serum samples. The test is designed for the selective measurement of infliximab by a sandwich immunoassay.
  • Measures from 0.4 to 20 µg/mL. The target concentrations for trough level interpretation lies well within the linear range of the test.
  • Provides a quantitative result within 15 minutes of incubation time. This offers the possibility to health care providers to act immediately before infusion of the next IFX dose.
  • Unique in the diagnostics market, being the only test that can provide fast, reliable TDM for IFX and it correlates well with the standard routine ELISAs for IFX level determinations.

The Quantum Blue® IFX assay measures from 0.4 to 20 µg/ml, and the target concentrations lies well within the linear range of the test. Quantum Blue® IFX provides a quantitative result within 15 minutes of incubation time. Quantum Blue® IFX is unique, being the only test that can provide fast, reliable information for IFX and correlating well with the standard routine ELISAs for determination of infliximab levels.

Quantum Blue® IFX Product Information

Test Quantum Blue® IFX
Method Lateral Flow
Time to Result 15 min (approx.)
Sample Type Serum
Measuring Range 0.4-20 µg/ml
Catalog Number see below

Download IFU and Catalog Numbers

View the appropriate tab below and click on the blue underlined catalog number to view the Instructions for Use.

Quantum Blue® Reader 3rd Generation-
•   BI-POCTR-ABS- Reader User Manual [EN]
•    Quick Guide – Fail Safe Mode [EN]
•    Quick Guide – Fast Track Mode [EN]

Quantum Blue® Reader 2nd Generation User Manual-
•   BI-POCTR-ABS- Reader User Manual [EN]

Related Quantum Blue® assays:

BÜHLMANN Quantum Blue® fCAL High RangeLF-CHR25-U
BÜHLMANN Quantum Blue® fCAL extendedLF-CALE25-U
BÜHLMANN Quantum Blue® ADL – LF-TLAD25-U/LF-TLAD10-U
BÜHLMANN Quantum Blue® Anti-ADL Antibodies – LF-ADAD25-U/LF-ADAD10-U
BÜHLMANN Quantum Blue® IFX – LF-TLIF25/LF-TLIF10
BÜHLMANN Quantum Blue® Anti-IFX Antibodies – LF-ADIF25-U/LF-ADIF10-U

BÜHLMANN Products are distributed in Canada by Inter Medico.  For more information, email info@inter-medico.com or call 1.800.387.9643.

IFX Flyer for US [EN]

IFX Flyer for Canada [EN]

IFX Flyer [FR] (coming soon)

TDM Pipeline Flyer [EN] (coming soon)

USA
Visit our contact page to enter your requests for quotations or to submit an order inquiry.
News and Events
Visit our News page to learn about upcoming events, the latest news about new products, studies at BÜHLMANN.